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Abstract
This study aimed at characterizing the impact of type 2 diabetes mellitus (T2DM) on the bone marrow mesenchymal stem cell (BMMSC) secre-
tome and angiogenic properties. BMMSCs from Zucker diabetic fatty rats (ZDF) (a T2DM model) and Zucker LEAN littermates (control) were
cultured. The supernatant conditioned media (CM) from BMMSCs of diabetic and control rats were collected and analysed. Compared to results
obtained using CM from LEAN-BMMSCs, the bioactive content of ZDF-BMMSC CM (i) differently affects endothelial cell (HUVEC) functions
in vitro by inducing increased (3.5-fold; P < 0.01) formation of tubule-like structures and migration of these cells (3-fold; P < 0.001), as well
as promotes improved vascular formation in vivo, and (ii) contains different levels of angiogenic factors (e.g. IGF1) and mediators, such as
OSTP, CATD, FMOD LTBP1 and LTBP2, which are involved in angiogenesis and/or extracellular matrix composition. Addition of neutralizing
antibodies against IGF-1, LTBP1 or LTBP2 in the CM of BMMSCs from diabetic rats decreased its stimulatory effect on HUVEC migration by
approximately 60%, 40% or 40%, respectively. These results demonstrate that BMMSCs from T2DM rats have a unique secretome with distinct
angiogenic properties and provide new insights into the role of BMMSCs in aberrant angiogenesis in the diabetic milieu.
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Introduction
Type 2 diabetes mellitus (T2DM) is reaching epidemic proportions
worldwide. The persistent hyperglycaemic milieu in T2DM is associ-
ated with macro- and micro-vascular complications affecting the
heart, blood vessels, eyes, kidney and nerves, and the wound-healing
process in diabetic patients [1–3]. Most of the T2DM pathological
complications are associated with impaired vascularization and/or
aberrant angiogenesis. Excessive and abnormal angiogenesis plays a
pivotal role in diabetic retinopathy and nephropathy [4, 5], whereas
deficient angiogenesis contributes to impaired wound healing and
coronary collateral vessel development [1, 3, 6]. Despite extensive
research, the mechanism(s) behind the abnormal angiogenesis bal-
ance in diabetic patients is still poorly understood.
Scientific research has provided evidence that the dysfunction of
different types of cells, including endothelial, peripheral blood and
bone marrow mesenchymal stem cells (BMMSCs), is related to the
reduced blood vessel regenerative potential in T2DM [7–9]. Endothe-
lial cells migrate in response to soluble mediators that regulate new
blood vessel formation [10], but their function is impaired in the dia-
betic milieu [7, 11, 12]. BMMSCs, whose phenotype is strongly deter-
mined by their specific environment, have the capacity to home in on
sites of injury, proliferate and differentiate into multilineage cell types
[13]. The T2DM milieu affects the regenerative potential of BMMSCs
as well as their proliferation [8], restricts their multipotency and
impairs their capacity to augment post-ischemic neovascularization in
diabetic mice [14]. BMMSCs exert a paracrine effect by the release of
growth factors and cytokines, such as IGF-1, which stimulate
endothelial cell migration [15], inhibit endothelial apoptosis and pro-
mote angiogenesis [16]. Moreover, by providing proangiogenic fac-
tors, BMMSCs create a favourable microenvironment that promotes
neovascularization and tissue regeneration [13, 15, 17]. Although
important in this respect, the impact of T2DM on the BMMSC secre-
tome and its angiogenic properties has not yet been characterized.
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We hypothesized, therefore, that the BMMSC secretome in the
diabetic milieu has a different composition and affects angiogene-
sis-related endothelial cell (EC) functions, including proliferation
and new blood vessel formation. We tested this hypothesis using
Zucker diabetic fatty (ZDF) (Leprfa/fa) rats (a model of T2DM)
and Zucker Lean control (LEAN) (Leprfa/+/Lepr+/+) rats (their
age-matched littermates) [18]. By focusing on the impact of
T2DM on BMMSC secretome functions, this study aimed at both
elucidating the contribution of MSCs in diabetic-related vascular
complications and establishing relevant aspects for future cell
therapies in diabetes.
Materials and methods
Animal models
Adult, 8-week-old, male, Swiss nude mice as well as adult, 12- to 13-
week-old, male, obese Zucker fa/fa rats (ZDF) and their lean fa/+ litter-
mates (LEAN) were purchased from Charles River (L’Arbresle, France).
The animals were housed, operated and killed using procedures in
accordance with the European Community Standards on the Care and
Use of Laboratory Animals. The experimental procedures were approved
by the Ethics Committee of the University Paris-Diderot.
The diabetic condition of the rats used in this study was determined
on the day of killing them. For this purpose, venous blood was col-
lected, and the respective glycaemic state was evaluated using a glu-
cometer (Roche Diagnostics, Meylan, France). Plasma concentrations of
glucose and fructosamine were determined using commercially available
kits (Roche Diagnostics) following the manufacturer’s instructions.
In vitro experiments
Isolation of rat mesenchymal stem cells (BMMSCs)
The femurs and tibiae from each rat were cleaned of connective tissues,
and their respective epiphyses were removed to allow insertion of 23-
gauge needles connected to syringes containing serum-free aMEM
(Invitrogen, Cergy Pontoise, France). The cells present in the harvested
marrow were then homogenized using complete medium composed of
aMEM supplemented with 10% (v/v) foetal calf serum and 1% (v/v)
antibiotic/antimycotic (ATB/ATM) solution (PAA Laboratories GmbH,
Pasching, Austria). The isolated cells from rats were seeded at 5 9 105
cells/cm² and cultured at 37°C in a humidified 5% CO2/95% air environ-
ment. After 2 days of culture, the supernatant media (containing non-
adherent cells) were discarded. Fibroblastic colonies (CFU-F) appeared
at day 5 of culture and were all pooled at day 12 (cell passage 1). For
amplification of the LEAN- and ZDF-BMMSC populations, the cells were
seeded at 10 9 103 cells/cm². The supernatant media were changed
twice a week. BMMSCs at passage 2–3 were used for the experiments
of this study.
Preparation of conditioned media
BMMSCs were seeded at 104/cm² in a culture-treated flask and cultured
in calf serum-free aMEM under standard cell culture conditions. After
24 hrs, the supernatant was collected, centrifuged (700 9 g, for
4 min.), aliquoted and frozen at 80°C until further use. The concentra-
tion of total proteins in the conditioned medium (CM) of BMMSCs from
both ZDF and LEAN rats was determined using the Bradford protein
assay and following the manufacturer’s instructions. For experiments
with neutralizing antibodies, anti-IGF-1, anti-LTBP1 or anti-LTBP2 were
added to CM (5 ng/mL) and maintained at 37°C for 1 hr before use in
experiments with cells.
Culture of HUVECs
The effects of CM on endothelial cells were studied using human umbil-
ical vein endothelial cells (HUVECs). HUVECs in EGM-2 medium (Lonza,
France) supplemented with 5% foetal calf serum and 1% (v/v) ATB/
ATM were cultured in tissue-culture flasks pre-coated with 0.5% gelatin
under standard cell culture conditions. When the cells reached 80%
confluency, they were passaged by trypsinization (Trypsin/EDTA
Solution, Life Technologies, Alfortville, Ile de France, France).
Cell proliferation
Cells were seeded at the density of 3 9 103 cells/cm2 in individual wells
of 12-well culture plates in aMEM containing 10% FBS. For each time-
point, BMMSCs were trypsinized, incubated with Trypan blue and
counted using a Malassez chamber.
Migration of human umbilical vein endothelial
cells in Boyden chambers
HUVEC migration was determined using commercially available Boyden
chambers (Corning Costar, Tewksbury MA, USA) whose two compart-
ments were separated by polycarbonate membranes with 8 lm diame-
ter pores. Aliquots of cells (50 9 103 cells) in 100 ll of aMEM without
foetal calf serum were placed in the upper chamber, and the various
media of interest to this study were each placed in the bottom chamber.
The cell migration experiments were conducted in a humidified, 37°C,
5% CO2/95% air environment for 24 hrs. The cells that had transversed
but still adhered on the other side of the membrane separating the Boy-
den chamber were then stained in situ using May Grunwald-Giemsa
stain. All such membranes were excised, mounted on slides, visualized
using light microscopy and photographed.
Wound-healing assay
HUVECs were seeded at a density that resulted in ~70–80% confluence
on the bottom surface of individual wells of 12-well tissue-culture plates
within 24 hrs of culture. At that time, each monolayer was scratched
across the respective centre using a new 1-ml pipette tip and was
rinsed twice with phosphate-buffered saline (PBS) to remove detached
cells. The wounded HUVEC samples were then treated with CM from
either BMMSCs of diabetic or control rats at 37°C for 6 hrs, rinsed
twice with PBS and fixed using 4% paraformaldehyde for 30 min. The
scar region on each cell monolayer was visualized using light micro-
scopy and photographed before and after the 6-hr interval. Comparison
of the evidence on these two sets of micrographs was used to deter-
mine the migration of HUVECs. These data were expressed as the
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difference in the distance travelled by HUVECs from the edges of each
scratch region towards the centre of the wounded area.
Formation of tubular-like structures by HUVECs
on Matrigel
Each well of 48-well tissue-culture plates was coated with 10 mg/ml
Matrigel (growth factor reduced Matrigel, VWR France) and maintained
in a humidified, 37°C, 5% CO2/95% air environment for 1 hr. Then,
5 9 104 cells in various media were added and cultured in a 37°C, 5%
CO2/95% air environment for 24 hrs. At that time, four random areas
were visualized using light microscopy, photographed and analysed for
the presence of tubular-like structures. The total length of the formed
tubular-like formation was measured using commercially available Ima-
geJ software.
3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay
HUVECs were seeded at 104 cells per each well of 96-well plates in var-
ious media (containing 150 lM of H2O2) in a humidified, 37°C, 5%
CO2/95% air environment for 90 min. At that time, the cells were rinsed
with PBS, and the MTT assay (Life Technologies) was performed. The
results provided evidence regarding cell viability after challenge by
H2O2.
ROS measurement
To measure reactive oxygen species (ROS) production in HUVECs,
DCFH-DA, an oxidation-sensitive indicator, was used. In the presence of
ROS, DCFH is oxidized to fluorescent 20,70-dichlorofluorescein (DCF),
which can be measured by fluorometry. For this purpose, HUVECs were
seeded at 104 cells/well in 96-well cell culture plates. The supernatant
medium was removed, and DCFH-DA was added at a concentration of
10 lM per well. These specimens were kept at 37°C for 1 hr. At that
time and after rinsing the cells with PBS, CM from BMMSCs of either
diabetic or control rats was added. Oxidative stress was induced using
tert-butyl hydroperoxide (Luperox, t-BuOOH Sigma-Aldrich (St. Louis,
MO, USA) at 100 lM. Fluorescence intensity of the samples was mea-
sured using a fluorescence spectrophotometer at excitation and emis-
sions wavelengths of 485 nm and 530 nm, respectively.
RNA extraction, reverse transcription and
quantitative polymerase chain reaction
(qRT-PCR)
Expression of select angiogenic markers by BMMSCs was determined
using total RNA that had been extracted from these cells using TRIzol
reagent (Life Technologies) according to the manufacturer’s protocols.
Real-time PCR was performed using an iCycler thermocycling appara-
tus (MyiQTM Single-Color Real-Time PCR, Bio-Rad Laboratories, Mar-
nes-la-Coquette, France). After activation of the DNA polymerase at
95°C for 10 min., cDNA was amplified by performing 40 two-step
PCR cycles: a 15 sec. denaturation step at 95°C, followed by a
60 sec. annealing and an extension step at 60°C. The Multiplex used
contained 84 angiogenic-related genes (the rat angiogenesis RT² Pro-
filer PCR Array, Qiagen).
Each sample was run in triplicate, and each analysis was repeated
on four separate occasions. Data were analysed using MyiQTM Software
(Bio-Rad Laboratories). The data were normalized with respect to
results obtained from LEAN-BMMSCs.
ELISA analysis
The level of 7 mediators (VEGF, IL-6, TNFa, MCP-1, FGF-2, IGF1 and
PLAU) were determined in the respective supernatant media at each
time-point of interest to this study using different ELISA kits and fol-
lowing the manufacturer’s instructions. These experiments were con-
ducted in triplicate and repeated on three separate occasions. A five-
parameter regression formula was used to calculate concentrations of
the respective mediators using standard curves for each mediator
assessed.
Proteomic analysis
Each supernatant CM from LEAN and ZDF-BMMSCs was separately
concentrated and desalted using an Amicon Ultra-2 Centrifugal device
column (Millipore, France). Briefly, 500 ll of each conditioned medium
tested was loaded in a column and centrifuged at 4500 9 g for 75 min.
This treatment resulted in a 10-fold increase in protein concentration.
The proteins in the concentrated CM were then analysed using a mass
spectrometer (LTQ-Orbitrap, Thermo Scientific, Waltham, MA, USA) at
the Jacques-Monod Institute (Paris, France). The data were normalized
with respect to results obtained from LEAN-BMMSCs.
In vivo experiments
Matrigel plug assay
Samples of supernatant CM from either LEAN-BMMSCs or ZDF-
BMMSCs, in aMEM either supplemented with 10% foetal calf serum or
serum-free, were freeze-dried using a Christ Alpha 1-2 freezer-drier
overnight. At that time, 500 lg protein from each dried CM sample was
mixed with 500 ll of ice-cold Matrigel (growth factor reduced Matrigel,
VWR, France) and was injected subcutaneously into the flanks of 8-
week-old Swiss nude mice [19]. After 14 days, the mice were killed,
and each Matrigel implant was excised, placed in 500 ll of RIPA buffer,
and processed using a Retsch MM 300 tissue lyser at 30 pulses/min.
for 2 min. The haemoglobin content in each excised implant was deter-
mined using a commercially available assay (Hemoglobin Colorimetric
Assay kit, Cayman Ann Arbor, MI, USA). Plugs were also embedded in
paraffin, sectioned, and stained with Masson’s trichrome.
Statistical analysis
Each experiment of this study was performed in triplicate and repeated
with three independent experiments using different cell preparations.
Numerical data are reported as the mean  standard error of the mean
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(SEM). Student’s t-tests for unpaired two-tailed samples were used for
statistical analyses of the experimental data and compared to the
respective controls. P value of < 0.05 was considered statistically sig-
nificant.
Results
CM from BMMSCs of diabetic rats affects HUVEC
functions
To characterize the impact of diabetes type 2 (T2DM) on the
BMMSC secretome, the effect of CM on selected functions (specif-
ically migration, proliferation, viability and reactive oxygen species
production) of HUVECs as well as in vitro and in vivo angiogene-
sis was examined.
CM from BMMSCs of diabetic rats increases
HUVEC vascular-like tube formation in vitro
The angiogenic potential of CM collected from either ZDF-BMMSCs
(CM-ZDF) or LEAN-BMMSCs (CM-LEAN) was determined using
HUVECs on Matrigel in the presence of CM-ZDF, CM-LEAN, aMEM
containing 10% FBS (FM) or FBS-free aMEM (NCM) for 24 hrs
(Fig. 1A). The CM-LEAN group was the reference in this experiment.
The supernatant CM-ZDF induced a significantly (P < 0.01) increased
(3.5-fold) formation of HUVEC tubular-like structures compared to
results obtained with either supernatant CM-LEAN or NCM (Fig. 1A
Fig. 1 Conditioned supernatant medium
from BMMSCs of diabetic rats promotes
tubular-like formation by HUVECs. (A)
Representative images of HUVECs in CM-
LEAN, CM-ZDF, FM or NCM cultured on
Matrigel for 24 hrs showing formation of
tubular-like structures. Scale
bar = 100 lm. (B) Quantification of the
tubular-like structures formed by HUVECs
in CM-LEAN, CM-ZDF, FM or NCM cul-
tured on Matrigel. Data are expressed as
a percentage of the results obtained with
CM-LEAN (group control). (C) Protein
content in the supernatant CM-LEAN, CM-
ZDF, FM and NCM. Values are mean 
SEM of four randomly selected fields on
each Matrigel surface tested. **P < 0.01,
***P < 0.001. CM-LEAN: supernatant,
conditioned medium from BMMSCs of
control rats. CM-ZDF: supernatant, condi-
tioned medium from BMMSCs of diabetic
rats. FM: Alpha MEM containing 10% foe-
tal bovine serum (FBS) not exposed to
cells. NCM: FBS-free alpha MEM not
exposed to cells.
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and B). The protein content in the CM-LEAN and CM-ZDF was similar
(Fig. 1C), but lower (P < 0.01) than that in the FM (Fig. 1C). These
results suggest that MSCs from diabetic rats secrete soluble, bioac-
tive, angiogenic mediators into their supernatant medium that affect
HUVEC tube-like formation.
CM from BMMSCs of diabetic rats promoted
increased HUVEC migration in vitro
The chemotactic potential of CM was examined using both the tran-
swell cell migration assay and the in vitro scratch wound-healing
assay. HUVEC migration through the porous transwell membrane
(8 lm pore diameter) was observed after 24 hrs with CM-LEAN, CM-
ZDF or FM, but not when NCM was used as the chemoattractant
(Fig. 2A). Compared with either CM-LEAN or FM, CM-ZDF induced
significantly (P < 0.001) increased (3-fold) migration of HUVECs
(Fig. 2B). After 6 hrs, HUVEC migration in the scratch wound-healing
assay was significantly (P < 0.01) enhanced (1.4-fold) in the pres-
ence of CM-ZDF compared to results obtained with either CM-LEAN
or FM (Fig. 2C and D). These results provide evidence that BMMSCs
from diabetic rats secrete soluble, bioactive, chemotactic mediators
into their supernatant media, which promote HUVEC migration.
CM from BMMSCs of diabetic rats does not
affect either HUVEC proliferation or viability and
has a limited effect on reactive oxygen species
production
The effect of the supernatant CM collected from either ZDF-BMMSCs
or LEAN-BMMSCs after 24 hrs of culture on the proliferation of
HUVECs was assessed. For this purpose, HUVECs were cultured in
CM-LEAN, CM- ZDF, FM or NCM, and their proliferation was deter-
mined over a period of up to 7 consecutive days. Compared to results
obtained from the other conditions tested, HUVECs cultured in FM
exhibited increased proliferation starting at day 3; this trend increased
by 4-fold at day 7 of culture (Fig. 3A). The HUVECs did not survive in
the absence of serum in the supernatant media (Fig. 3A). HUVECs
cultured with either CM-LEAN or CM-ZDF survived but did not
Fig. 2 Conditioned supernatant medium
from BMMSCs of diabetic rats induces
increased HUVEC migration. HUVEC
migration was determined using Boyden
chambers. (A) Representative images
showing HUVEC migration. Stain: Giemsa.
Scale bar = 200 lm. (B) Number of
migrated HUVECs in the presence of CM-
LEAN, CM-ZDF, FM or NCM. HUVECs
using the in vitro scratch wound-healing
assay. (C) Distance of migrated HUVECs
exposed to supernatant CM-LEAN, CM-
ZDF, FM or NCM. (D) Representative light
micrographs of the scratch area after
6 hrs. The dotted lines delineate the origi-
nal scratched area after 6 hrs. Scale
bar = 100 lm. Data are expressed as a
percentage of the results obtained from
the control (CM-LEAN) group. Values are
mean  SEM of four fields on each sur-
face tested. *P < 0.05, **P < 0.01,
***P < 0.001. CM-LEAN: supernatant,
conditioned medium from BMMSCs of
control rats. CM-ZDF: supernatant, condi-
tioned medium from BMMSCs of diabetic
rats. FM: alpha MEM containing 10% foe-
tal bovine serum (FBS), not exposed to
cells. NCM: FBS-free alpha MEM not
exposed to cells.
ª 2016 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
5
J. Cell. Mol. Med. Vol XX, No X, 2016
proliferate over the 7 days of the experiments. Moreover, the number
of HUVECs under either CM-ZDF or CM-LEAN was similar for the
duration of the experiments (Fig. 3A). The effect of the various super-
natant CM on HUVEC viability after challenge with H2O2 was assessed
by exposing HUVECs to 150 lM of H2O2 in each medium of interest
to this study for 90 min. HUVECs exposed to CM-LEAN, CM-ZDF or
NCM had similar numbers of cells, which were significantly
(P < 0.001) higher than those observed under FM (Fig. 3B).
Furthermore, upon exposure to either CM-LEAN or CM-ZDF,
production of ROS by HUVECs was higher when the cells were
exposed to CM-ZDF than to CM-LEAN; this difference in ROS was
approximately 15% after 1 hr of measurement (P < 0.001)
(Fig. 3C).
CM from BMMSCs of diabetic rats promotes
increased neoangiogenesis in vivo
To evaluate the proangiogenic potential of the CM-ZDF in vivo, Matri-
gel plugs were implanted in a mouse model. These Matrigel plugs,
prepared using either CM-ZDF or CM-LEAN (each containing 500 lg/
ml of proteins), as well as either NCM or FM, were injected into the
flanks of nude mice and were implanted for a 14-day period. At that
time, the explanted plugs containing NCM, CM-LEAN or FM were pale
in colour, indicating no or little blood vessel content (Fig. 4A). In con-
trast, plugs containing CM-ZDF appeared dark red due to the pres-
ence of red blood cells, indicating the formation of blood vessels
(Fig. 4A and B). Compared to plugs prepared with either CM-LEAN or
NCM, the implanted Matrigel plugs containing CM-ZDF had a signifi-
cant (P < 0.05) increase (2.5-fold) in haemoglobin content (Fig. 4C).
In conjunction with the in vitro results, these in vivo data provided
evidence that supernatant CM from ZDF-BMMSCs promotes
increased angiogenesis in vivo.
BMMSCs of diabetic rats differentially express
angiogenic genes
The underlying mechanism(s) of the observed increased angiogenesis
of the CM-ZDF was explored by determining the expression of 84
Fig. 3 Conditioned supernatant medium
from BMMSCs of either diabetic or
healthy rats has no effect on either
HUVEC proliferation or viability when chal-
lenged by H2O2, and a limited effect on
reactive oxygen species production. (A)
Proliferation of HUVECs in the presence of
supernatant CM-LEAN, CM-ZDF, FM and
NCM cultured for up to 7 days. (B)
HUVEC apoptosis determined using the
MTT assay. HUVECs were exposed to
150 lM of H2O2 in supernatant CM-LEAN,
CM-ZDF, FM or NCM for 90 min. (C) ROS
production by HUVECs exposed to either
CM-LEAN or CM-ZDF for 5 hrs. A.U.: arbi-
trary units. Values are mean  SEM.
***P < 0.001. CM-LEAN: supernatant,
conditioned medium from BMMSCs of
control rats. CM-ZDF: supernatant, condi-
tioned medium from BMMSCs of diabetic
rats. FM: alpha MEM containing 10% foe-
tal bovine serum (FBS) not exposed to
cells. NCM: FBS-free alpha MEM not
exposed to cells.
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known angiogenic genes in BMMSCs. Nine pro-angiogenic genes,
including alanyl aminopeptidase (ANPEP) (3-fold), monocyte
chemoattractant protein-1 (MCP-1) (3-fold), macrophage inflamma-
tory protein 2-alpha (MIP-2) (3-fold), hypoxia-inducible factor 2
(HIF-2) (2-fold), IGF-1 (5.5-fold), interleukin 6 (IL-6) (2-fold),
urokinase-type plasminogen activator (PLAU) (2-fold), tyrosine
kinase with immunoglobulin-like and EGF-like domains 1 (TIE1)
(5.5-fold) and tumour necrosis factor alpha (TNFa) (4-fold), were
significantly (P < 0.05) up-regulated in ZDF-BMMSCs. In addition,
eight anti-angiogenic genes, including collagen type XVIII alpha 1
(COL18A1) (2-fold), collagen type IV alpha 3 (COL4A3) (8-fold),
coagulation Factor II (F2) (2-fold), interferon gamma (INFc) (2-
fold), Sphingosine-1-phosphate receptor 1 (S1PR1) (3-fold), Ser-
pine1 (3-fold), transforming growth factor beta 1 (TGFb1) (3-fold)
and transforming growth factor beta 3 (TGFb3) (2-fold), were
down-regulated in ZDF-BMMSCs (Fig. 5A). Several other angio-
genic mediators, including vascular endothelial growth factor alpha
(VEGFa), fibroblast growth factor 2 (FGF2), epidermal growth fac-
tor (EGF) and hypoxia-inducible factor 1 alpha (HIF1a), were
expressed similarly by both ZDF-BMMSCs and LEAN-BMMSCs
(data not shown).
ELISA analysis of the protein content in the conditioned media
provided evidence that among the five different mediators tested, only
the content of IGF-1 correlated (P < 0.001) with the observed differ-
ence in gene expression due to ZDF-BMMSCs (Fig. 5B). The concen-
trations of IL-6, MCP-1 and PLAU were similar in CM from LEAN- and
ZDF-BMMSCs. TNFa and FGF were not detected in all media tested
(Fig. 5B), while the VEGF concentration was significantly (P < 0.001)
lower in ZDF-BMMSCs. The presence of bioactive IGF-1 in CM from
ZDF-BMMSCs was confirmed by the reduced (by 60%; P < 0.001)
HUVEC migration when this CM was supplemented with antibodies
against IGF-1 (Fig. 6A and B). Blocking IGF-1 in CM from ZDF-
BMMSCs did not affect the formation of tubular structures (Fig. 6C
and D).
A
C
B
Fig. 4 Conditioned supernatant medium
from BMMSCs of diabetic rats enhances
in vivo angiogenesis. Matrigel plugs
(500 ll) containing proteins (500 lg)
from freeze-dried supernatant CM-ZDF,
CM-LEAN, FM or NCM were injected sub-
cutaneously into the flanks of nude mice.
After 14 days, these Matrigel plugs were
excised and photographed, and their hae-
moglobin contents were quantified. (A)
Representative photographs of the excised
Matrigel plugs. Scale bar = 1 mm. (B)
Representative photograph of sectioned
paraffin-embedded Matrigel plugs stained
with Masson’s trichrome (the arrowhead
indicates capillaries with red blood cells).
Scale bar = 20 lm (C) Quantification of
the haemoglobin contents in the excised
Matrigel plugs. Values are mean  SEM;
n = 6 per experimental group. *P < 0.05.
CM-LEAN: supernatant, conditioned med-
ium from BMMSCs of control rats. CM-
ZDF: supernatant, conditioned medium
from BMMSCs of diabetic rats. FM: alpha
MEM containing 10% FBS not exposed to
cells. NCM: FBS-free alpha MEM not
exposed to cells.
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Fig. 5 Expression of angiogenic gene mediators is modified in BMMSCs of diabetic rats. (A) Expression of select pro-angiogenic genes (black bars)
and anti-angiogenic genes (grey bars) in ZDF-MSCs relative to results obtained from LEAN-MSsC. (B) ELISA results of the analysis of overexpressed
pro-angiogenic genes in samples from ZDF-MSCs. Values are mean  SEM. n = 3. ***P < 0.001. LEAN-MSCs: BMMSCs from control rats. ZDF-
MSC: BMMSCs from diabetic rats. CM-LEAN: supernatant, conditioned medium from BMMSCs of control rats. CM-ZDF: supernatant conditioned
medium from BMMSCs of diabetic rats.
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CM from BMMSCs of diabetic rats overexpressed
several extracellular matrix proteins related to
angiogenesis
Proteomic analysis of the supernatant CM from either diabetic or con-
trol BMMSCs revealed over 2-fold (P < 0.05) up-regulation of 27 and
down-regulation of 17 proteins in the CM-ZDF (Fig. 7A). Eight pro-
teins related to glucose metabolism, specifically aldolase, fructose-
bisphosphate A (ALDOA) (by 2-fold), lactate dehydrogenase A (LDHA)
(by 2.5-fold), pyruvate kinase, muscle (KPYM) (by 2.5-fold), glucose-
6-phosphate (G6P) (by 2.5-fold), prothymosin, alpha (PTMA) (by 3-
fold), 20-50-oligoadenylate synthetase 2 (OAS2) (by 2-fold), aldehyde
dehydrogenase 1 (ALD1) (by 4-fold) and insulin-like growth factor
binding protein 2 (IBP2) (by 2.5-fold), were differentially expressed
and down-regulated in the CM of ZDF-BMMSCs (Fig. 7B). This result
indicates the possible modification of glucose metabolism in the
BMMSCs from diabetic rats.
Fig. 6 IGF-1 in CM-ZDF promotes migra-
tion of HUVECs but not tubular formation.
HUVEC migration assays were performed
using the in vitro scratch/wound-healing
assay. (A) Distance of migrated HUVECs
exposed to either supernatant CM-ZDF or
CM-ZDF containing a blocking antibody
for IGF-1. (B) Representative light micro-
graphs of the scratch area after 6 hrs.
The dotted lines delineate the original
scratched area after 6 hrs. Scale
bar = 100 lm. (C) Representative images
of HUVECs in either CM-ZDF without or
CM-ZDF with a blocking antibody for IGF-
1 (anti-IGF-1) cultured on Matrigel for
24 hrs. Scale bar = 100 lm. (D) Quantifi-
cation of the tubular-like structures
formed by HUVECs in either CM-ZDF with-
out or CM-ZDF with blocking antibody for
IGF-1 cultured on Matrigel. Data are
expressed as a percentage of the results
obtained with CM-ZDF without anti-IGF-1
(control group). Values are mean  SEM
of four fields on each surface tested.
***P < 0.001.
ª 2016 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
9
J. Cell. Mol. Med. Vol XX, No X, 2016
10 ª 2016 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Several proteins whose genes were overexpressed by the ZDF-
BMMSCs are either extracellular matrix components or are involved
in the process of extracellular matrix remodelling (Fig. 7C), including
latent transforming growth factor beta binding protein 1 (LTBP1)
(2-fold), latent transforming growth factor beta binding protein
2 (LTBP2) (2-fold), osteopontin (OSTP) (5-fold), phosphatidylglyc-
erophosphate synthase 1 (PGS1) (2-fold), coiled-coil domain
containing 80 (CCD80) (4-fold), alamin adenosyltransferase (COBA1)
(5-fold), cathepsin L1 (CATL1) (2-fold), nucleobindin 1 (NUCB1)
(2-fold), nidogen 1 (NID1) (2-fold), serine protease 23 (PRS23) (2-
fold), ADAM metallopeptidase with thrombospondin type 1 motif,
1(ATS1) (2-fold), serum amyloid P (SAP) (3-fold) and fibromodulin
(FMOD) (5-fold).
Some of these components could be related to angiogenesis and
may be involved in the observed enhanced chemotactic response of
endothelial cells (Fig. 7D). In fact, among the proteins differentially
expressed in ZDF-BMMSC CM, seven proteins, specifically LTBP1 (2-
fold), LTBP2 (2-fold), OSTP (5-fold), cathepsin D (CATD) (2-fold), SAP
(2-fold) and FMOD (5-fold), are related to angiogenesis and were over-
expressed (Fig. 7D). Blocking either LTBP1 or LTBP2 in the CM from
ZDF-BMMSCs resulted in a decrease (by 40%) of the stimulatory effect
of these chemical compounds on HUVEC migration (Fig. 8A and B) but
Fig. 7 The content of angiogenic mediators in conditioned medium (CM) from BMMSCs of diabetic rats and of controls is different Proteomic analy-
sis of the protein content in supernatant CM-ZDF compared to the results obtained from CM-LEAN. Down-regulated and overexpressed proteins are
shown in red and green, respectively, in all frames. (A) Proteins that were differentially expressed in supernatant CM-ZDF compared to CM-LEAN
(B) Proteins present in the supernatant CM-ZDF that are related to the extracellular matrix. (C) Proteins present in the supernatant CM-ZDF that are
related to glucose metabolism. (D) Proteins present in the supernatant CM-ZDF that are related to angiogenesis. Values are mean  SEM. n = 3.
P < 0.05. CM-LEAN: supernatant, conditioned medium from BMMSCs of control rats. CM-ZDF: supernatant, conditioned medium from BMMSCs of
diabetic rats.
Fig. 8 Specific extracellular matrix proteins
(LTBP-1 and LTBP-2) are involved in the
enhanced migration of CM-ZDF. HUVEC
migration assays were performed using
the in vitro scratch/wound-healing assay.
(A) Distances migrated by HUVECs
exposed to either supernatant CM-ZDF or
CM-ZDF in the presence or absence of
blocking antibodies for either LTBP-1 or
LTBP-2 or both. (B) Representative light
micrographs of the scratch area 6 hrs
post cell injury. The dotted lines delineate
the original scratched area after 6 hrs.
Scale bar = 100 lm. (C) Representative
images of HUVECs in either CM-ZDF or
CM-ZDF and in the presence or absence
of blocking antibodies for LTBP-1, LTBP-2
or both, cultured on Matrigel for 24 hrs.
Scale bar = 100 lm. (D) Quantification of
the tubular-like structures formed by
HUVECs exposed to either CM-ZDF or
CM-ZDF in the presence or absence of
blocking antibodies for LTBP-1, LTBP-2,
or both, cultured on Matrigel for 24 hrs.
Data are expressed as percentage of the
results obtained when the cells were cul-
tured in CM-ZDF (control group). Values
are mean  SEM of four fields on each
surface tested. *P < 0.05, **P < 0.01.
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did not affect tubular structure formation (Fig. 8C and D). These results
indicate that compared to the secretome of control BMMSCs, the
secretome of ZDF-BMMSCs contains matrix-related proteins (such as
LTBP1 or LTBP2) and promotes angiogenesis (Fig. 8).
Discussion
Despite the fact that BMMSC-derived paracrine factors were reported
to be largely involved in neovascularization and tissue repair, the
impact of type 2 diabetes mellitus (T2DM) on the BMMSC secretome
and its effects on angiogenesis are still unknown [16, 17]. We, there-
fore, performed a comparative analysis of the BMMSC secretome and
its effects on endothelial cells, using ZDF rats at 13 weeks to repre-
sent early diabetic conditions and their LEAN littermates as controls.
The results obtained provided the first evidence that short-term
T2DM alters the BMMSC secretome composition and promotes
angiogenic capabilities.
The results of this study demonstrated that angiogenesis-related
genes are differently expressed in BMMSCs from ZDF rats when com-
pared with results from LEAN animals. In fact, several pro-angiogenic
genes were overexpressed, while anti-angiogenic genes were down-
regulated (Fig. 5). The up-regulated (over 5-fold) genes included IGF-1
and TIE1, which are critical regulators of angiogenesis [20], MCP-1
and IL-6, homing factors for BMMSCs and EC/EPCs, respectively [21,
22], and IL-6 and TNFa, critical mediators of the inflammatory process.
Nevertheless, the expression of several angiogenic genes did not corre-
late with the released protein levels in the supernatant CM in this study.
Analysis of the protein content in the 24-hr secreted CM from LEAN-
and ZDF-BMMSCs provided evidence that among the different media-
tors tested, only the content of IGF-1 correlated (P < 0.001) with the
observed difference in gene expression by ZDF-BMMSCs (Fig. 5B).
However, proteomic analysis did not reveal IGF1 in the CM. This imper-
fect and variable correlation between ELISA and proteomic analysis can
be explained by different levels of sensitivity and dynamic ranges of the
methods [23]. The concentrations of IL-6, MCP-1 and PLAU were simi-
lar in CM from LEAN- and ZDF-BMMSCs, while that of VEGF was lower
in ZDF-BMMSCs. TNFa and FGF were not detected in all media tested.
IGF-1 plays a significant role in the physiology of endothelial cells by
promoting their migration [20, 24]. IGF-1 is also overexpressed by sev-
eral types of cells implicated in T2DM-proliferative retinopathy [25, 26].
Under our experimental conditions, IGF-1 released by ZDF-BMMSCs
accounted for approximately 60% of the observed enhanced HUVEC
migration (Fig. 6A and B). The IGF-1 effect is mediated by activation of
the IGF-1 receptor, which triggers several signalling pathways and
therefore several cellular responses. For instance, the Ras/Raf pathway
is critical for proliferative responses, whereas activation of Rac is
important for cell migration [27]. This study provides evidence that
IGF-1 might be a key factor in the paracrine action of T2DM-BMMSCs
on endothelial cell behaviour, thus contributing to the pathogenesis of
microvascular complications associated with the diabetic condition,
including diabetic retinopathy.
Moreover, proteomic analysis of the T2DM-BMMSC secretome
revealed some proteins that are related to angiogenesis through several
mechanisms. Specifically, the results showed (i) decreased levels of
ab-crystallin, a chaperone for VEGF-A, and (ii) increased levels of
LTBP1 and LTBP2, regulators of TGF-b availability [28], as well as of
OSTP and FMOD, which are components of the extracellular matrix and
might be involved in the paracrine action of T2DM-BMMSCs on
endothelial cells [29–32]. The role of extracellular matrix components
in angiogenesis has been highlighted by both in vitro and in vivo stud-
ies [33, 34]. In this respect, this study revealed a different secretory
profile of BMMSCs that may explain how these cells affect the environ-
mental niche and paradoxical angiogenesis in the diabetic milieu. ROS
stands at the cross-point of the regulations exerted on the BMMSCs as
a signalling molecule in the bone marrow environment [35]. For
instance, low levels of ROS are associated with quiescent MSCs,
whereas an increased ROS level is typical of proliferating cultures.
In addition, the proteomic analysis of T2DM-BMMSC CM demon-
strated a specific secretory phenotype of extracellular matrix remod-
elling and glucose metabolism. Compared to LEAN-BMMSCs, of the
261 proteins released by ZDF-BMMSCs, 44 were differentially
secreted, with 27 at higher and 17 at lower levels (Fig. 7). The 27
overexpressed proteins included extracellular matrix homeostasis and
remodelling-related molecules [36]. In contrast, proteins involved in
the metabolism of glucose (such as ALDOA, LDHA, KPYM, G6P,
PTMA, OAS2, ALD1 and IBP2) were secreted at lower levels (Fig. 7C).
Impaired glucose metabolism was already observed in T2DM muscle
cells [37], but to our knowledge, this is the first report in the BMMSC
secretome. Targeting such molecules may offer insight into the
underlying mechanisms of T2DM-BMMSC physiology.
Compared with LEAN-BMMSCs, the ZDF-BMMSC secretome was
unique, despite the fact that ZDF-BMMSCs were extensively expanded
by ex vivo culture at normal glucose levels. These findings show that
the effects of the diabetic milieu were evident on the BMMSCs, even
after multiple cell divisions in vitro in a normoglycaemic environment.
Moreover, these results corroborate literature reports that aspects of
the diabetic condition, particularly hyperglycaemia, induce transmissi-
ble alterations in many type of cells, including endothelial, vascular
smooth muscle, retinal and cardiac cells [38]. In fact, the process by
which hypo-methylation of gene promoters leads to deregulated gene
expression in T2DM is known as ‘metabolic memory’ [38, 39] and is
implicated in the persistence of vascular complications of diabetes,
even after return to normal blood glucose levels [38, 39]. Regarding
ZDF rats, alteration of hepatic DNA methylation at early diabetic con-
ditions (12 weeks) was previously reported [40]. For this reason, it is
possible that the altered secretome observed in ZDF-BMMSCs is due
to a ‘metabolic memory’ phenomenon. Further studies are needed to
determine whether such changes are initiated during the pre-diabetic
state in the ZDF rat model.
This study is the first to directly compare both in vitro and in vivo
the angiogenic potential of BMMSC-CM from T2DM and control ani-
mals. In line with previous studies reporting the angiogenic potential
of the BMMSC secretome [17, 41], BMMSC-CM from both, ZDF rats
and age-matched LEAN rats also showed angiogenic properties.
These results corroborated previous studies establishing that healthy
rat BMMSCs and CM-BMMSC improve the formation of HUVEC tubu-
lar structure in both paracrine [41, 42] and juxtacrine manners [41].
The CM from BMMSCs, however, affected endothelial cell functions
differently. It promoted HUVEC migration and tube formation with no
12 ª 2016 The Authors.
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change in proliferation. Such differences are due to changes in the
levels of several bioactive compounds, such as IGF-1, LTBP1 and
LTBP2, and reflect the interactive and possible synergistic action of
those multiple bioactive mediators leading to a promotion of angio-
genesis. Another plausible explanation for the differences in effects of
CM from BMMSCs on HUVEC functions may be the relative concen-
trations of paracrine factors. For instance, IGF-1-related effects are
mediated by activation of IGF-1 receptors, which trigger, among
others, the Rac pathway. This pathway is important for cell migration
but not proliferation [27]. Our findings are in line with Gruber et al.
[43] who suggested that MSCs paracrine effects might not be respon-
sible for the initiation of the angiogenic process, but rather would play
a role in guiding the growing blood vessels. However, in contrast with
these data, Kinnaird et al. [17] reported that human BMMSCs MC
increases EC proliferation. The reasons from these mixed and dis-
crepant results are not really surprising if one takes into consideration
the differences in isolation methods, species (rat versus human) and
EC sources use [44]. Moreover, in this study, CM from rat BMMSCs
induced vascular formation in matrigel plugs in vivo. These findings
are in line with previous studies [45] that show the occurrence of
functional blood vessels in rBMMSC-CM loaded Matrigel plugs. Taken
together, these data indicate that BMMSCs secretome may contribute
to EPCs recruitment and subsequent formation of functional vessels.
Another important result of this study is that the CM from T2DM–
BMMSCs increased in vitro endothelial cell migration and tubular
structure formation, as well as in vivo vascular formation in matrigel
transplants (Fig. 4). The greater angiogenic potential of T2DM–
BMMSCs secretome may reflect the interactive actions of multiple
bioactive mediators (including IGF-1, LTBP1 and LTBP2) which may
alter the functions of endothelial cells, key players in diabetic vascular
complications [46]. Angiogenesis results from an equilibrium
between pro- and anti-angiogenic factors [46]. The increased angio-
genesis observed in this study may arise from a disturbed balance
between these pro- and anti-angiogenic factors and highlights the
paracrine effect of an altered BMMSCs secretome on endothelial cells.
It further illustrates the ambiguous role of angiogenesis in the patho-
genesis of diabetic vascular complications. Thus, exacerbated angio-
genesis occurs in diabetic retinopathy and nephropathy, whereas
reduced angiogenesis contributes to diabetic impaired wound healing.
A similar response to that observed in this study had been reported
for BMMSCs cultured under in vitro hypoxic and high glucose condi-
tions used to mimic the diabetic environment in vitro [47, 48]. This
increase in angiogenic response may reflect the ‘adaptive’ BMMSC
response to the severe stress conditions of the diabetic milieu.
Because CM delivers paracrine/trophic angiogenic factors, it is impor-
tant to take these aspects of diabetic pathology into consideration in
the development of BMMSC-based therapies aimed at improving tis-
sue repair in diabetes. Last but not least, the findings reported here
are somewhat different from the results of Dzhoyashvili et al. [49]
who have shown that CM from human diabetic adipose tissue exhib-
ited a reduced angiogenic potential. These apparently contradictory
data further illustrate the complexity the pathogenesis of diabetic vas-
cular complications and deserve supplementary investigations to fully
decipher the molecular basis of MSC paracrine effects in diabetes.
A limitation of this study is the fact that it is difficult to separate
the effects of hyperglycaemia from those of obesity. The ZDF rat was
chosen as the animal model because these animals initially develop
insulin resistance followed by T2DM at predictable ages and display
many of the human T2DM characteristics, including obesity, abnor-
mal blood lipid profiles, and related vascular complications [18], mak-
ing them a clinically relevant model.
In summary, this study provided the first evidence that compared
with control animals, BMMSCs from T2DM rats exhibit an altered
secretome pattern and angiogenic properties and underline the critical
role of paracrine factors of MSC-mediated angiogenesis in the dia-
betic milieu. These results provide valuable insight in the vascular
complications associated with diabetes and could be used in the
development of BMMSC-based therapies to improve diabetic tissue
repair.
Acknowledgements
We gratefully acknowledge the help of Prof. Rena Bizios for critically reviewing
this article. We also thank Dr. Graciela Pavon-Djavid for expert help with ROS
production. This study was supported by the ‘Ministere de la recherche’ (2011/
47) ‘Fondation Francaise pour la Recherche Medicale’ (FRM)
(FDT20140930864), the ‘Fondation de l’Avenir’ (ET3-694) and the Institut
Francais pour la Recherche Odontologique (IFRO).
Author contributions
J.R.: data research, analysis, and interpretation and manuscript writ-
ing; G.C.: data analysis; J.P.: data interpretation; C.B-V: data analysis,
design and interpretation; H.P.: discussion and final approval of
manuscript; F.A.: conception, design, data analysis and interpretation
and manuscript writing.
Conflict of interest
The authors declare that they have no conflicts of interest.
References
1. Martin A, Komada MR, Sane DC. Abnormal
angiogenesis in diabetes mellitus. Med Res
Rev. 2003; 23: 117–45.
2. Oikawa A, Siragusa M, Quaini F, et al. Dia-
betes mellitus induces bone marrow
microangiopathy. Arterioscler Thromb Vasc
Biol. 2010; 30: 498–508.
3. Tahergorabi Z, Khazaei M. Imbalance of
angiogenesis in diabetic complications: the
mechanisms. Int J Prev Med. 2012; 3: 827–38.
4. Abu El-Asrar AM, Nawaz MI, Kangave D,
et al. Angiogenesis regulatory factors in the
vitreous from patients with proliferative dia-
betic retinopathy. Acta Diabetol. 2013; 50:
545–51.
ª 2016 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
13
J. Cell. Mol. Med. Vol XX, No X, 2016
5. Abu El-Asrar AM, Struyf S, Kangave D,
et al. Chemokines in proliferative diabetic
retinopathy and proliferative vitreoretinopa-
thy. Eur Cytokine Netw. 2006; 17: 155–65.
6. Golden SH. Emerging therapeutic
approaches for the management of diabetes
mellitus and macrovascular complications.
Am J Cardiol. 2011; 108: 59B–67B.
7. Gealekman O, Brodsky SV, Zhang F, et al.
Endothelial dysfunction as a modifier of
angiogenic response in Zucker diabetic fat
rat: amelioration with Ebselen. Kidney Int.
2004; 66: 2337–47.
8. Shin L, Peterson DA. Impaired therapeutic
capacity of autologous stem cells in a model
of type 2 diabetes. Stem Cells Transl Med.
2012; 1: 125–35.
9. Roberts AC, Porter KE. Cellular and molecu-
lar mechanisms of endothelial dysfunction in
diabetes. Diabetes Vasc Dis Res. 2013; 10:
472–82.
10. Sumpio BE, Riley JT, Dardik A. Cells in
focus: endothelial cell. Int J Biochem Cell
Biol. 2002; 34: 1508–12.
11. Capla JM, Grogan RH, Callaghan MJ, et al.
Diabetes impairs endothelial progenitor cell-
mediated blood vessel formation in response
to hypoxia. Plast Reconstr Surg. 2007; 119:
59–70.
12. Kang L, Chen Q, Wang L, et al. Decreased
mobilization of endothelial progenitor cells
contributes to impaired neovascularization
in diabetes. Clin Exp Pharmacol Physiol.
2009; 36: e47–56.
13. Watt SM, Gullo F, van der Garde M,
et al. The angiogenic properties of mes-
enchymal stem/stromal cells and their
therapeutic potential. Br Med Bull. 2013;
108: 25–53.
14. Yan J, Tie G, Wang S, et al. Type 2 diabetes
restricts multipotency of mesenchymal stem
cells and impairs their capacity to augment
postischemic neovascularization in db/db
mice. J Am Heart Assoc. 2012; 1: e002238.
15. Pacini S, Petrini I. Are MSCs angiogenic
cells? New insights on human nestin-posi-
tive bone marrow-derived multipotent cells.
Front Cell Dev Biol. 2014; 2: 20.
16. Hung SC, Pochampally RR, Chen SC, et al.
Angiogenic effects of human multipotent
stromal cell conditioned medium activate the
PI3K-Akt pathway in hypoxic endothelial
cells to inhibit apoptosis, increase survival,
and stimulate angiogenesis. Stem Cells.
2007; 25: 2363–70.
17. Kinnaird T, Stabile E, Burnett MS, et al.
Marrow-derived stromal cells express genes
encoding a broad spectrum of arteriogenic
cytokines and promote in vitro and in vivo
arteriogenesis through paracrine mecha-
nisms. Circ Res. 2004; 94: 678–85.
18. Etgen GJ, Oldham B. Profiling of Zucker dia-
betic fatty rats in their progression to the
overt diabetic state. Metabolism. 2000; 49:
684–88.
19. Benslimane-Ahmim Z, Heymann D, Dizier
B, et al. Osteoprotegerin, a new actor in
vasculogenesis, stimulates endothelial col-
ony-forming cells properties. J Throm Hae-
most. 2011; 9: 834–43.
20. Shigematsu S, Yamauchi K, Nakajima K,
et al. IGF-1 regulates migration and angio-
genesis of human endothelial cells. Endocr
J. 1999; 46(Suppl): S59–62.
21. Middleton K, Jones J, Lwin Z, et al. Inter-
leukin-6: an angiogenic target in solid
tumours. Crit Rev Oncol Hematol. 2014; 89:
129–39.
22. Salcedo R, Ponce ML, Young HA, et al.
Human endothelial cells express CCR2 and
respond to MCP-1: direct role of MCP-1 in
angiogenesis and tumor progression. Blood.
2000; 96: 34–40.
23. Ranganath SH, Levy O, Inamdar MS, et al.
Harnessing the mesenchymal stem cell
secretome for the treatment of cardiovascu-
lar disease. Cell Stem Cell. 2012; 10: 244–
58.
24. Bach LA. Endothelial cells and the IGF sys-
tem. J Mol Endocrinol. 2015; 54: R1–13.
25. Romaniuk D, Kimsa MW, Strzalka-Mrozik
B, et al. Gene expression of IGF1, IGF1R,
and IGFBP3 in epiretinal membranes of
patients with proliferative diabetic retinopa-
thy: preliminary study. Mediators Inflamm.
2013; 2013: 986217.
26. Beltramo E, Lopatina T, Berrone E, et al.
Extracellular vesicles derived from mes-
enchymal stem cells induce features of dia-
betic retinopathy in vitro. Acta Diabetol.
2014; 51: 1055–64.
27. Delafontaine P, Song YH, Li Y. Expression,
regulation, and function of IGF-1, IGF-1R,
and IGF-1 binding proteins in blood vessels.
Arterioscler Thromb Vasc Biol. 2004; 24:
435–44.
28. Tatti O, Vehvilainen P, Lehti K, et al. MT1-
MMP releases latent TGF-beta1 from
endothelial cell extracellular matrix via prote-
olytic processing of LTBP-1. Exp Cell Res.
2008; 314: 2501–14.
29. Todorovic V, Rifkin D. LTBPs, more than
just an escort service. J Cell Biochem. 2012;
113: 410–8.
30. Kale S, Raja R, Thorat D, et al. Osteo-
pontin signaling upregulates cyclooxyge-
nase-2 expression in tumor-associated
macrophages leading to enhanced
angiogenesis and melanoma growth via
alpha9beta1 integrin. Oncogene. 2014; 33:
2295–306.
31. Berchem G, Glondu M, Gleizes M, et al.
Cathepsin-D affects multiple tumor progres-
sion steps in vivo: proliferation, angiogenesis
and apoptosis. Oncogene. 2002; 21: 5951–5.
32. Jian J, Zheng Z, Zhang K, et al. Fibromod-
ulin promoted in vitro and in vivo angiogene-
sis. Biochem Biophys Res Commun. 2013;
436: 530–5.
33. Neve A, Cantatore FP, Maruotti N, et al.
Extracellular matrix modulates angiogenesis
in physiological and pathological conditions.
BioMed Res Int. 2014; 2014: 756078.
34. Sottile J. Regulation of angiogenesis by
extracellular matrix. Biochim Biophys Acta.
2004; 1654: 13–22.
35. Lyublinskaya OG, Borisov YG, Pugovkina
NA, et al. Reactive oxygen species are
required for human mesenchymal stem cells
to initiate proliferation after the quiescence
exit. Oxid Med Cell Longev. 2015; 2015:
502105.
36. Monnier VM, Mustata GT, Biemel KL, et al.
Cross-linking of the extracellular matrix by
the maillard reaction in aging and diabetes:
an update on ‘a puzzle nearing resolution’.
Ann N Y Acad Sci. 2005; 1043: 533–44.
37. Gao Y, Wu F, Zhou J, et al. The H19/let-7
double-negative feedback loop contributes
to glucose metabolism in muscle cells.
Nucleic Acids Res. 2014; 42: 13799–811.
38. Reddy MA, Zhang E, Natarajan R. Epige-
netic mechanisms in diabetic complications
and metabolic memory. Diabetologia. 2015;
58: 443–55.
39. Park LK, Maione AG, Smith A, et al. Gen-
ome-wide DNA methylation analysis identi-
fies a metabolic memory profile in patient-
derived diabetic foot ulcer fibroblasts. Epige-
netics. 2014; 9: 1339–49.
40. Williams KT, Schalinske KL. Tissue-specific
alterations of methyl group metabolism with
DNA hypermethylation in the Zucker (type 2)
diabetic fatty rat. Diabetes Metab Res Rev.
2012; 28: 123–31.
41. Mohammadi E, Nassiri SM, Rahbarghazi R,
et al. Endothelial juxtaposition of distinct
adult stem cells activates angiogenesis sig-
naling molecules in endothelial cells. Cell
Tissue Res. 2015; 362: 597–609.
42. Li H, Zuo S, He Z, et al. Paracrine factors
released by GATA-4 overexpressed mes-
enchymal stem cells increase angiogenesis
and cell survival. Am J Physiol Heart Circ
Physiol. 2010; 299: H1772–81.
43. Gruber R, Kandler B, Holzmann P, et al.
Bone marrow stromal cells can provide a
14 ª 2016 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
local environment that favors migration and
formation of tubular structures of endothelial
cells. Tissue Eng. 2005; 11: 896–903.
44. Bronckaers A, Hilkens P, Martens W, et al.
Mesenchymal stem/stromal cells as a phar-
macological and therapeutic approach to
accelerate angiogenesis. Pharmacol Ther.
2014; 143: 181–96.
45. Rahbarghazi R, Nassiri SM, Khazraiinia P,
et al. Juxtacrine and paracrine interactions
of rat marrow-derived mesenchymal stem
cells, muscle-derived satellite cells, and
neonatal cardiomyocytes with endothelial
cells in angiogenesis dynamics. Stem Cells
Dev. 2013; 22: 855–65.
46. Costa PZ, Soares R. Neovascularization in
diabetes and its complications. Unraveling
the angiogenic paradox. Life Sci. 2013; 92:
1037–45.
47. Page P, DeJong J, Bandstra A, et al. Effect
of serum and oxygen concentration on gene
expression and secretion of paracrine fac-
tors by mesenchymal stem cells. Int J Cell
Biol. 2014; 2014: 601063.
48. Deschepper M, Oudina K, David B, et al.
Survival and function of mesenchymal stem
cells (MSCs) depend on glucose to over-
come exposure to long-term, severe and
continuous hypoxia. J Cell Mol Med. 2011;
15: 1505–14.
49. Dzhoyashvili NA, Efimenko AY, Kochegura
TN, et al. Disturbed angiogenic activity of
adipose-derived stromal cells obtained from
patients with coronary artery disease and
diabetes mellitus type 2. J Transl Med.
2014; 12: 337.
ª 2016 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
15
J. Cell. Mol. Med. Vol XX, No X, 2016
